Product Images Duloxetine Delayed-release
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 11 images provide visual information about the product associated with Duloxetine Delayed-release NDC 63629-1992 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - duloxetine 01
Figure 1 - duloxetine 02
This is a graphical representation of the proportion of patients with relapse over time from randomization to relapse in days, comparing the treatment of Duloxstine delayed-release capsules versus a placebo. The graph shows that patients who took Duloxstine had a lower proportion of relapse compared to the placebo group.*
Figure 2 - duloxetine 03
This appears to be a graph displaying the proportion of patients with relapse over time for two different treatments. The treatments are labeled as "Placebo" and "Duloxeine delayed-release capsules". The x-axis represents the time from randomization to relapse in days, ranging from 0 to 300 days. The y-axis represents the proportion of patients with relapse, ranging from 0 to 1. Unfortunately, without additional context or information, the purpose or meaning of the graph cannot be determined.*
Figure 3 - duloxetine 04
Figure 4 - duloxetine 05
Figure 5 - duloxetine 06
Figure 6 - duloxetine 07
Figure 8 - duloxetine 08
Figure 9 - duloxetine 09
The text represents a chart showing the percentage of patients' improvement and the percentage of improvement in pain from baseline based on two treatments: Placebo and DUL 60 mg taken once daily. The chart shows that for both treatments, there were 8 patients who showed improvement. However, at 100%, DUL had more patients show improvement compared to placebo. The text also shows that there was a steady increase in the percentage of improvement in pain from baseline for patients taking both treatments, with a range of 50 to 100, measured by the BOCF method.*
Figure 10 - duloxetine 10
This is a chart that shows the percentage of patients who have experienced improvements in pain levels after taking a placebo or DUL60/120mg once daily. The chart also shows different pain improvement percentages, ranging from 0 to 80. There is no additional information available.*
Label - lbl636291992
This is a description of the medication "Duloxetine Delayed-Release Capsules, USP" by NILD. Each capsule contains 60mg of Duloxetine Hydrochloride. It is important to keep this medication out of reach of children and store it between 20° to 25°C (68° to 77°F). The medication should be dispensed in a tight, light-resistant container with a child-resistant closure. The National Drug Code (NDC) number for this medication is 63629-1992-1 and it must be prescribed by a doctor.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
